Ambrx Biopharma Current Ratio 2020-2021 | AMAM
For a detailed definition, formula and example for Current Ratio, check out our new background page here.
Ambrx Biopharma current ratio from 2020 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Ambrx Biopharma Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2021-06-30 |
$0.17B |
$0.02B |
9.90 |
| 2020-12-31 |
$0.09B |
$0.01B |
7.02 |
| 2019-12-31 |
$0.02B |
$0.02B |
1.22 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.322B |
$0.014B |
|
Ambrx Biopharma Inc. is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. Ambrx Biopharma Inc. is based in SAN DIEGO.
|
